Proqr Therapeutics (PRQR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2014 | 09-2014 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | 149,860 | 152,930 |
| Other current assets | 1,540 | 800 |
| TOTAL | $151,400 | $153,730 |
| Non-Current Assets | ||
| Other Non-Current Assets | 210 | 50 |
| TOTAL | $210 | $50 |
| Total Assets | $153,190 | $154,750 |
| Liabilities | ||
| Current Liabilities | ||
| Accounts payable and accrued liabilities | 1,650 | 1,460 |
| Other current liabilities | 2,300 | 2,010 |
| TOTAL | $4,000 | $3,490 |
| Non-Current Liabilities | ||
| Long Term Debt | 3,740 | 3,650 |
| TOTAL | $3,760 | $3,700 |
| Total Liabilities | $7,760 | $7,190 |
| Shareholders' Equity | ||
| Common Shares | 1,240 | 1,230 |
| Retained earnings | -21,000 | -18,250 |
| Other shareholders' equity | 920 | 590 |
| TOTAL | $145,430 | $147,550 |
| Total Liabilities And Equity | $153,190 | $154,740 |